Completed PHASE2 INTERVENTIONAL 2-arm NCT02215434

Safety Study of Transdermal Testosterone for Low Libido in Pre and Postmenopausal Women (TESTOSTERONE)

Phase 2 Study of Transdermal Testosterone for Low Libido in Pre and Postmenopausal Women

Sponsor: Federal Institute of Science and Technology of Ceara

Interventions Biolipid B2 (blanked/placebo) Testosterone, Transdermal, Behavior

Updated 4 times since 2017 Last updated: Aug 12, 2014 Started: Sep 30, 2009 Primary completion: Apr 30, 2013 Completion: Aug 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Sex Behavior and is currently completed. Federal Institute of Science and Technology of Ceara leads this study, which shows 4 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jan 2017 — Jan 2021 [monthly]

Completed PHASE2

First recorded

Sep 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Federal Institute of Science and Technology of Ceara
Universidade Federal do Ceara
University Potiguar

Data source: University Potiguar

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Natal, Brazil